Over 11,000 people work in our Pharmaceutical, Vaccines and Consumer Healthcare R&D organisations, in major research centres around the world.
We have two global pharmaceutical R&D hubs in Stevenage, UK and Upper Providence, near Philadelphia in the USA, focused on research across our four core therapy areas: Respiratory, HIV & Infectious Diseases, Oncology and Immuno-inflammation.
We have three global vaccine R&D hubs located in Belgium, Italy and the USA, researching vaccines against bacterial, viral and parasitic pathogens.
Find out more
How we discover new medicines
Researching and developing a new medicine typically goes through several stages from laboratory to patient
How we discover new vaccines
Our vaccines R&D is focused on discovering prophylactic and therapeutic vaccines to protect people against infectious diseases, cancers and chronic disorders.
Consumer healthcare research
GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business
We share expertise, resources, intellectual property and know-how with external researchers and the scientific community to promote change beyond GSK